| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |